Ecovyst Q4 sales growth beat analyst expectations

Reuters
02/26
Ecovyst Q4 sales growth beat analyst expectations

Overview

  • Sulfuric acid provider's Q4 sales rose 33.9% yr/yr, beating analyst expectations

  • Adjusted net income for Q4 beat analyst expectations

  • Company completed sale of Advanced Materials & Catalysts segment for $556 mln

Outlook

  • Ecovyst expects 2026 sales between $860 mln and $940 mln

  • Company anticipates 2026 adjusted EBITDA of $175 mln to $195 mln

  • Ecovyst projects 2026 adjusted net income of $55 mln to $75 mln

Result Drivers

  • VIRGIN SULFURIC ACID - Higher sales volume, including contribution from Waggaman acquisition, drove sales increase

  • REGENERATED SULFURIC ACID - Favorable pricing offset by lower sales volume due to customer downtime

  • SULFUR COSTS - Pass-through effect of higher sulfur costs added $28 million to sales

Company press release: ID:nPn46RSCga

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Beat

$199.40 mln

$184.90 mln (5 Analysts)

Q4 Adjusted Net Income

Beat

$32.40 mln

$17.51 mln (5 Analysts)

Q4 Net Income

$5.80 mln

Q4 Adjusted EBITDA

Beat

$51.30 mln

$48.62 mln (6 Analysts)

Q4 Gross Profit

$46.80 mln

Q4 Operating Income

$21.80 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ecovyst Inc is $12.00, about 6% above its February 25 closing price of $11.32

  • The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 13 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10